| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to 5-(4'-hydroxyphenyl)- and 5-(2',5'-dihydroxyphenyl)-6H-1,3,4-thiadiazine-2-amines, hydrohalogenides of general formulas and inhibiting thrombocyte aggregation in the intravenous introduction NR 1 R 1 -morpholino-; thiomorpholino-; pyrrolidino-; piperidino-; hexamethyleneimino-, HHal - HCl; HBr. n EFFECT: given compounds may be used for preparing cardiologic drugs and enable better treatment of various cardiovascular diseases, including myocardial infarction and thrombotic apoplexy. n 1 cl, 6 tbl, 2 dwg, 10 ex |